The utilization of web search activity for pandemic forecasting has significant implications for managing disease spread and informing policy decisions. However, web search records tend to be noisy and influenced by geographical location, making it difficult to develop large-scale models. While regularized linear models have been effective in predicting the spread of respiratory illnesses like COVID-19, they are limited to specific locations. The lack of incorporation of neighboring areas' data and the inability to transfer models to new locations with limited data has impeded further progress. To address these limitations, this study proposes a novel self-supervised message-passing neural network (SMPNN) framework for modeling local and cross-location dynamics in pandemic forecasting. The SMPNN framework utilizes an MPNN module to learn cross-location dependencies through self-supervised learning and improve local predictions with graph-generated features. The framework is designed as an end-to-end solution and is compared with state-of-the-art statistical and deep learning models using COVID-19 data from England and the US. The results of the study demonstrate that the SMPNN model outperforms other models by achieving up to a 6.9% improvement in prediction accuracy and lower prediction errors during the early stages of disease outbreaks. This approach represents a significant advancement in disease surveillance and forecasting, providing a novel methodology, datasets, and insights that combine web search data and spatial information. The proposed SMPNN framework offers a promising avenue for modeling the spread of pandemics, leveraging both local and cross-location information, and has the potential to inform public health policy decisions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10853009 | PMC |
http://dx.doi.org/10.1109/ichi57859.2023.00027 | DOI Listing |
Clin Oncol (R Coll Radiol)
December 2024
Faculty of Medicine and Health Sciences, University of Antwerp, Prinsstraat 13, 2000, Antwerp, Belgium; Department of Radiation Oncology, Iridium Netwerk, Oosterveldlaan 22, 2610, Antwerp, Belgium. Electronic address:
Aim: Tumour-infiltrating lymphocytes (TILs) represent a promising cancer biomarker. Different TILs, including CD8+, CD4+, CD3+, and FOXP3+, have been associated with clinical outcomes. However, data are lacking regarding the value of TILs for patients receiving radiation therapy (RT).
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Hepatobiliary Surgery, The Third Central Hospital of Tianjin, Tianjin, China.
Background: In patients with advanced hepatocellular carcinoma (HCC) following sorafenib failure, regorafenib has been used as an initial second-line drug. It is unclear the real efficacy and safety of sorafenib-regorafenib sequential therapy compared to placebo or other treatment (cabozantinib or nivolumab or placebo) in advanced HCC.
Methods: Four electronic databases (PubMed, Embase, Web of Science, and Ovid) were systematically searched for eligible articles from their inception to July, 2024.
JMIR Ment Health
January 2025
Inspire, Belfast, United Kingdom.
Background: There is potential for digital mental health interventions to provide affordable, efficient, and scalable support to individuals. Digital interventions, including cognitive behavioral therapy, stress management, and mindfulness programs, have shown promise when applied in workplace settings.
Objective: The aim of this study is to conduct an umbrella review of systematic reviews in order to critically evaluate, synthesize, and summarize evidence of various digital mental health interventions available within a workplace setting.
J Neurosurg
January 2025
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing.
Objective: The aim of this study was to evaluate outcomes of deep brain stimulation (DBS) for Meige syndrome, compare the efficacy of globus pallidus internus (GPi) and subthalamic nucleus (STN) as targets, and identify potential outcome predictors.
Methods: The PubMed, Embase, and Web of Science databases were systematically searched to collect individual data from patients with Meige syndrome receiving DBS. Outcomes were assessed using the Burke-Fahn-Marsden Dystonia Rating Scale motor (BFMDRS-M) and disability (BFMDRS-D) scores.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!